Allianz Asset Management Gmb H Biocryst Pharmaceuticals Inc Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$6.96 - $8.81 $75,864 - $96,029	10,900 Added 48.66%	33,300 $234,000
Q1 2023 May 11, 2023	SELL	$7.94 - $11.84 $189,766 - $282,976	-23,900 Reduced 51.62%	22,400 $186,000
Q4 2022 Feb 13, 2023	SELL	$10.5 - $14.2 $140,700 - $190,280	-13,400 Reduced 22.45%	46,300 $531,000
Q3 2022 Nov 08, 2022	SELL	$10.79 - $14.81 $4.16 Million - $5.72 Million	-385,975 Reduced 86.6%	59,700 $752,000
Q2 2022 Aug 12, 2022	BUY	$7.89 - $17.88 $1.11 Million - $2.51 Million	140,496 Added 46.04%	445,675 $4.72 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $486,259 - $831,184	42,064 Added 15.99%	305,179 $4.96 Million
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $1.33 Million - $1.85 Million	119,407 Added 83.09%	263,115 $3.64 Million
Q3 2021 Nov 10, 2021	BUY	$14.21 - $17.65 $2.04 Million - $2.54 Million	143,708 New	143,708 $2.07 Million
Q3 2020 Nov 13, 2020	SELL	$3.43 - $5.53 $46,774 - $75,412	-13,637 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $25,910 - $76,503	13,637 New	13,637 $65,000
Q4 2019 Feb 13, 2020	SELL	$1.59 - $3.45 $171,545 - $372,220	-107,890 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$2.5 - $3.73 $393,135 - $586,557	-157,254 Reduced 59.31%	107,890 $309,000
Q2 2019 Aug 08, 2019	SELL	$2.91 - $9.15 $202,489 - $636,693	-69,584 Reduced 20.79%	265,144 $1.01 Million
Q1 2019 May 13, 2019	BUY	$7.38 - $9.72 $482,098 - $634,959	65,325 Added 24.25%	334,728 $2.73 Million
Q4 2018 Feb 14, 2019	SELL	$6.51 - $9.6 $58,687 - $86,544	-9,015 Reduced 3.24%	269,403 $2.17 Million
Q3 2018 Nov 13, 2018	BUY	$5.52 - $7.99 $264,987 - $383,559	48,005 Added 20.83%	278,418 $2.12 Million
Q2 2018 Aug 13, 2018	SELL	$4.6 - $6.52 $6,200 - $8,788	-1,348 Reduced 0.58%	230,413 $1.32 Million
Q1 2018 May 14, 2018	BUY	$4.35 - $5.82 $290,506 - $388,677	66,783 Added 40.48%	231,761 $1.11 Million
Q4 2017 Feb 13, 2018	BUY	$4.16 - $5.33 $23,354 - $29,922	5,614 Added 3.52%	164,978 $810,000
Q3 2017 Nov 13, 2017	BUY	$4.1 - $5.97 $171,080 - $249,110	41,727 Added 35.47%	159,364 $835,000
Q2 2017 Aug 14, 2017	SELL	N/A	-2,341 Reduced 1.95%	117,637 $654,000
Q1 2017 Apr 17, 2019	BUY	N/A	119,978	119,978 $1.01 Million

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$154 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$152 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$90.2 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$69 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67.3 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account